XML 38 R20.htm IDEA: XBRL DOCUMENT
v3.20.2

Revenues (Tables) | 6 Months Ended
--- | ---
Jul. 03, 2020
Revenue from Contract with Customer [Abstract] |
Schedule of Disaggregation of Revenue | Revenues consisted of the following (in thousands):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2020 |  | 2019 |  | 2020 |  | 2019
Product revenues: |  |  |  |  |  |  |
Gross product revenues | $ | 229,898 |  |  | $ | 240,418 |  |  | $ | 482,464 |  |  | $ | 464,168 |
Discounts and allowances | (51,168 | ) |  | (46,743 | ) |  | (109,854 | ) |  | (90,912 | )
Net product revenues | 178,730 |  |  | 193,675 |  |  | 372,610 |  |  | 373,256 |
Collaboration revenues: |  |  |  |  |  |  |
License revenues | 59,234 |  |  | 37,742 |  |  | 80,113 |  |  | 63,306 |
Collaboration services revenues | 21,515 |  |  | 8,858 |  |  | 33,671 |  |  | 19,200 |
Total collaboration revenues | 80,749 |  |  | 46,600 |  |  | 113,784 |  |  | 82,506 |
Total revenues | $ | 259,479 |  |  | $ | 240,275 |  |  | $ | 486,394 |  |  | $ | 455,762 |
Net product revenues by product were as follows (in thousands):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2020 |  | 2019 |  | 2020 |  | 2019
CABOMETYX | $ | 173,610 |  |  | $ | 189,015 |  |  | $ | 362,826 |  |  | $ | 364,905 |
COMETRIQ | 5,120 |  |  | 4,660 |  |  | 9,784 |  |  | 8,351 |
Net product revenues | $ | 178,730 |  |  | $ | 193,675 |  |  | $ | 372,610 |  |  | $ | 373,256 |
The percentage of total revenues by customer who individually accounted for 10% or more of our total revenues were as follows:
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2020 |  | 2019 |  | 2020 |  | 2019
Ipsen Pharma SAS (Ipsen) | 20 | % |  | 9 | % |  | 17 | % |  | 10 | %
Affiliates of CVS Health Corporation | 13 | % |  | 15 | % |  | 15 | % |  | 15 | %
Affiliates of McKesson Corporation | 11 | % |  | 13 | % |  | 13 | % |  | 12 | %
Affiliates of AmerisourceBergen Corporation | 11 | % |  | 10 | % |  | 11 | % |  | 10 | %
Affiliates of Optum Specialty Pharmacy | 10 | % |  | 8 | % |  | 11 | % |  | 8 | %
Takeda Pharmaceutical Company Limited (Takeda) | 10 | % |  | 1 | % |  | 5 | % |  | 3 | %
Accredo Health, Incorporated | 10 | % |  | 8 | % |  | 9 | % |  | 9 | %
Revenues by geographic region were as follows (in thousands):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2020 |  | 2019 |  | 2020 |  | 2019
U.S. | $ | 181,231 |  |  | $ | 196,347 |  |  | $ | 377,827 |  |  | $ | 378,473 |
Europe | 52,917 |  |  | 22,249 |  |  | 81,953 |  |  | 44,117 |
Japan | 25,331 |  |  | 21,679 |  |  | 26,614 |  |  | 33,172 |
Total revenues | $ | 259,479 |  |  | $ | 240,275 |  |  | $ | 486,394 |  |  | $ | 455,762 |
Schedule of Activities and Ending Reserve Balances for Significant Categories of Discounts and Allowances | The activities and ending reserve balances for each significant category of discounts and allowances, which constitute variable consideration, were as follows (in thousands):
| Chargebacks and Discounts for Prompt Payment |  | Other Customer Credits/Fees and Co-pay Assistance |  | Rebates |  | Total
Balance at December 31, 2019 | $ | 7,514 |  |  | $ | 3,497 |  |  | $ | 15,222 |  |  | $ | 26,233 |
Provision related to sales made in: |  |  |  |  |  |  |
Current period | 72,874 |  |  | 8,339 |  |  | 28,226 |  |  | 109,439 |
Prior periods | 39 |  |  | (364 | ) |  | 740 |  |  | 415 |
Payments and customer credits issued | (72,169 | ) |  | (9,111 | ) |  | (29,592 | ) |  | (110,872 | )
Balance at June 30, 2020 | $ | 8,258 |  |  | $ | 2,361 |  |  | $ | 14,596 |  |  | $ | 25,215 |

X
- Definition Reconciliation Of Sales Discount And Allowances Reserve Balances [Table Text Block] + References No definition available. + Details
Name: | exel_ReconciliationOfSalesDiscountAndAllowancesReserveBalancesTableTextBlock
Namespace Prefix: | exel_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration